Australian shares have rebounded impressively since April, but the real test will be the upcoming earnings season.

If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

One of these stocks finished the first half unchanged, and the other fell in the double-digits. Both represent great ...

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

Replimune (REPL) stock slides after as FDA rejects its melanoma drug RP1, boosting shares of Iovance Biotherapeutics (IOVA) which markets a rival drug. Read more here.

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for ...